Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Liu, Fang; Merchant, Hamid A.; Kulkarni, Rucha P.; Alkademi, Maram; Basit, Abdul W. (2011)
Publisher: Elsevier
Languages: English
Types: Article
Subjects: RS
The use of compendial pH 6.8 phosphate buffer to assess dissolution of enteric coated products gives rise to poor in vitro-in vivo correlations because of the inadequacy of the buffer to resemble small intestinal fluids. A more representative and physiological medium, pH 6.8 bicarbonate buffer, was developed to evaluate the dissolution behaviour of enteric coatings. The bicarbonate system was evolved from pH7.4 Hanks balanced salt solution to produce a pH 6.8 bicarbonate buffer (modified Hanks buffer, mHanks), which resembles the ionic composition and buffer capacity of intestinal milieu. Prednisolone tablets were coated with a range of enteric polymers: hypromellose phthalate (HP-50 and HP-55), cellulose acetate phthalate (CAP), hypromellose acetate succinate (HPMCAS-LF and HPMCAS-MF), methacrylic acid copolymers (EUDRAGIT® L100-55, EUDRAGIT® L30D-55 and EUDRAGIT® L100) and polyvinyl acetate phthalate (PVAP). Dissolution of coated tablets was carried out using USP-II apparatus in 0.1M HCl for 2h followed by pH 6.8 phosphate buffer or pH 6.8 mHanks bicarbonate buffer. In pH 6.8 phosphate buffer, the various enteric polymer coated products displayed rapid and comparable dissolution profiles. In pH 6.8 mHanks buffer, drug release was delayed and marked differences were observed between the various coated tablets, which is comparable to the delayed disintegration times reported in the literature for enteric coated products in the human small intestine. In summary, the use of pH 6.8 physiological bicarbonate buffer (mHanks) provides more realistic and discriminative in vitro release assessment of enteric coated formulations compared to compendial phosphate buffer.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Agyilirah, G.A. and G.S. Banker, Polymers for enteric coating and applications, in Polymers for controlled drug delivery, P.J. Tarcha, Editor. 1991, CRC press: Baca Raton. p. 39-66.
    • 2. Banwell, J.G., S.L. Gorbach, N.F. Pierce, R. Mitra, and A. Mondal, Acute undifferentiated human diarrhoea in the tropics. . J. Clin. Invest., 1971. 50: p. 890-900.
    • 3. Bianchini, R., M. Resciniti, and C. Vecchio, Technological evaluation of aqueous enteric coating systems with and without insoluble additives. Drug Dev. Ind. Pharm., 1991. 17: p. 1779-1794.
    • 4. Bogentoft, C., M. Alpsten, and G. Ekenved, Absorption of acetylsalicylic acid from enteric-coated tablets in relation to gastric emptying and in-vivo disintegration. J. Pharm. Pharmacol., 1984. 36: p. 350-351.
    • 5. Boni, J.E., R.S. Brickl, and J. Dressman, Is bicarbonate buffer suitable as a dissolution medium? J Pharm Pharmacol, 2007. 59(10): p. 1375-82.
    • 6. Bruce, L.D., H.U. Petereit, T. Beckert, and J.W. McGinity, Properties of enteric coated sodium valproate pellet. Int. J. Pharm., 2003. 264: p. 85-96.
    • 7. Chan, W.A., C.D. Boswell, and Z. Zhang, Comparison of the release profiles of a water soluble drug carried by Eudragit-coated capsules in different in-vitro dissolution liquids. Powder Tech., 2001. 119: p. 26-32.
    • 8. Cole, E.T., R.A. Scott, A.L. Connor, I.R. Wilding, H.U. Petereit, C. Schminke, T. Beckert, and D. Cade, Enteric coated HPMC capsules designed to achieve intestinal targeting. Int. J. Pharm., 2002(231): p. 83-95.
    • 9. Dangel, C., K. Kolter, H.B. Reich, and G. Schepky, Aqueous enteric coatings with methacrylic acid copolymer type C on acidic and basic drugs in tablets and pellets, Part I: acetylsalicylic acid tablets and crystals. Pharm. Tech., 2000: p. 64-70.
    • 10. Davis, M., I. Ichikawa, E.J. Williams, and G.S. Banker, Comparison and evaluation of enteric polymer properties in aqueous solutions. International Journal of Pharmaceutics, 1986. 28(2-3): p. 157-166.
    • 11. Dressman, J.B., R.R. Berardi, L.C. Dermentzoglou, T.L. Russell, S.P. Schmaltz, J.L. Barnett, and K.M. Jarvenpaa, Upper gastrointestinal (GI) pH in young, healthy men and women. Pharm. Res., 1990. 7: p. 756-761.
    • 12. Ebel, J.P., M. Jay, and R.M. Beihn, An in vitro/in vivo correlation for the disintegration and onset of drug release from enteric-coated pellets. Pharm. Res., , 1993. 10: p. 233-238.
    • 13. Eckersley, S.T. and A. Rudin, Mechanism of film formation from polymer latexes. J. Coatings Tech., 1990. 62: p. 89-100.
    • 14. Evans, D.F., G. Pye, R. Bramley, A.G. Clark, T.J. Dyson, and J.D. Hardcastle, Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut, 1988. 29: p. 1035-1041.
    • 15. Fadda, H.M. and A.W. Basit, Dissolution of pH responsive formulations in media resembling intestinal fluids: bicarbonate versus phosphate buffers. J. Drug Del. Sci. Technol., 2005. 15: p. 273- 279.
    • 16. Fadda, H.M. and A.W. Basit, Drug solubility in luminal fluids from different regions of the small and large intestine of humans. 2009. AAPS2009-003733.
    • 17. Fadda, H.M., H.A. Merchant, B.T. Arafat, and A.W. Basit, Physiological bicarbonate buffers: stabilisation and use as dissolution media for modified release systems. Int J Pharm, 2009. 382(1- 2): p. 56-60.
    • 18. Fallingborg, J., Intraluminal pH of the human gastrointestinal tract. Dan. Med. Bull., 1999. 46: p. 183-196.
    • 19. Garcia-Arieta, A., D. Torrado-Santiago, and J.J. Torrado, Comparative study of aqueous and organic enteric coatings of chlorpheniramine maleate tablets. Drug Dev. Ind. Pharm, 1996. 22: p. 579-585.
    • 20. Hardy, J.G., D.F. Evans, I. Zaki, A.G. Clark, H.H. Tonnesen, and O.N. Gamst, Evaluation of an enteric coated naproxen tablet using gamma scintigraphy and pH monitoring. Int. J. Pharm., 1987. 37: p. 245-250.
    • 21. Harianawala, A.I., R.H. Bogner, and M. Bradley, Measurement of pH near dissolving enteric coatings. Int J Pharm, 2002. 247(1-2): p. 139-46.
    • 22. Ibekwe, V.C., H.M. Fadda, G.E. Parsons, and A.W. Basit, A comparative in-vitro assessment of the drug release performance of pH responsive polymers for ileo-colonic delivery. Int. J. Pharm., 2006. 308: p. 52-60.
    • 23. Kararli, T.T., C.F. Kirchhoff, and J.E. Truelove, Ionic strength dependence of dissolution for Eudragit S-100 coated pellets. Pharm Res, 1995. 12(11): p. 1813-6.
    • 24. Lehmann, K., Chemistry and application properties of polymethacrylate coating systems, J.W. McGinity, Editor. 1989, Marcel Dekker, Inc.: New York. p. 153-245.
    • 25. Lindahl, A., A.L. Ungell, L. Knutson, and H. Lennernas, Characterization of fluids from the stomach and proximal jejunum in men and women. Pharm. Res., 1997. 14: p. 497-502.
    • 26. McConnell, E.L., H.M. Fadda, and A.W. Basit, Gut instincts: explorations in intestinal physiology and drug delivery. Int.J.Pharm., 2008. 364: p. 213-226.
    • 27. McNamara, D.P., K.M. Whitney, and S.L. Goss, Use of a physiologic bicarbonate buffer system for dissolution characterization of ionizable drugs. Pharm Res, 2003. 20(10): p. 1641-6.
    • 28. Narasimhan, B. and N. Peppas, The physics of polymer dissolution: Modeling approaches and experimental behaviour, in Polymer Analysis, Polymer Physics, A. Andrady, Editor. 1997, SpringerVerlag: New York. p. 157-207.
    • 29. Nesbitt, R.U., F.W. Goodhart, and R.H. Gordon, Evaluation of polyvinyl acetate phthalate as an enteric coating material. International Journal of Pharmaceutics, 1985. 26(3): p. 215-226.
    • 30. Nguyen, D.A. and H.S. Fogler, Facilitated diffusion in the dissolution of carboxylic polymers. AIChE Journal, 2005. 51(2): p. 415-425.
    • 31. Ozturk , S.S., B.O. Palsson, B. Donohoe, and J.B. Dressman, Kinetics of release from enteric-coated tablets. Pharm. Res., 1988. 5: p. 550-564.
    • 32. Phillips, S.F. and J. Giller, The contribution of the colon to electrolyte and water conservation in man. J Lab Clin Med, 1973. 81(5): p. 733-746.
    • 33. Schiller, C., C.P. Frohlich, T. Giessmann, W. Siegmund, H. Monnikes, N. Hosten, and W. Weitschies, Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging. Aliment. Pharmacol. Ther., 2005. 22: p. 971-979.
    • 34. Shek, E., Buffer capacity, not buffer catalysis, affects the dissolution rate of cellulose acetate phthalate. Pharm. Ind., 1978. 40: p. 981-982.
    • 35. Sheng, J.J., D.P. McNamara, and G.L. Amidon, Toward an in vivo dissolution methodology: a comparison of phosphate and bicarbonate buffers. Mol Pharm, 2009. 6(1): p. 29-39.
    • 36. Spitael, J. and R. Kinget, Factors affecting the dissolution rate of enteric coatings. Pharm. Ind., 1977. 39: p. 502-505.
    • 37. Spitael, J., R. Kinget, and K. Naessens, Dissolution rate of cellulose acetate phthalate and the Bronsted catalysis law. Pharm. Ind., 1980. 42: p. 846-849.
    • 38. Vanderhoff, J.W., H.L. Tarkowski, M.C. Jenkins, and E.B. Bradford, Theoretical considerations of the interfacial forces involved in the coalescence of latex particles. J. Macromol. Chem, 1966. 1: p. 361.
    • 39. Wilding, I.R., S.S. Davis, R.A. Sparrow, K.J. Smith, K.A. Sinclair, and A.T. Smith, The evaluation of an enteric-coated naproxen tablet formulation using gamma scintigraphy. Eur. J. Pharm. Biopharm, 1993. 39: p. 144-147.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article